489
Views
22
CrossRef citations to date
0
Altmetric
Research Article

The Emerging Role of Leptin Antagonist as Potential Therapeutic Option for Inflammatory Bowel Disease

, , , , , , , , & show all
Pages 23-33 | Accepted 18 Mar 2013, Published online: 10 Jul 2013

REFERENCES

  • Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–429.
  • Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928–937.
  • Greenberg GR, Fleming CR, Jeejeebhoy KN, Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Am J Clin Nutr 1989;49:573–579.
  • Ehrhardt RO, Ludviksson BR, Gray B, Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 1997;158:566–573.
  • Silk DB, Payne-James J. Inflammatory bowel disease: nutritional implications and treatment. Proc Nutr Soc 1989;48:355–361.
  • Rigaud D, Angel LA, Cerf M, Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr 1994;60:775–781.
  • De Gaetano A, Greco AV, Benedetti G, Increased resting lipid oxidation in Crohn's disease. JPEN: J Parenter Enteral Nutr 1996;20:38–42.
  • Powrie F, Leach MW. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther Immunol 1995;2:115–123.
  • Mombaerts P, Mizoguchi E, Grusby MJ, Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:274–282.
  • Hollander GA, Simpson SJ, Mizoguchi E, Severe colitis in mice with aberrant thymic selection. Immunity 1995;3:27–38.
  • Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344–1367.
  • Otero M, Lago R, Gomez R, Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006;45:944–950.
  • Zhang Y. Positional cloning of the mouse obese gene and its human homologue. [see comments.] [erratum appears in Nature 1995 Mar 30;374(6521):479]. Nature 1994;372:425–432.
  • Auwerx J, Staels B. Leptin. Lancet 1998;351:737–742.
  • Ahima RS, Prabakaran D, Mantzoros C, Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250–252.
  • Campfield LA, Smith FJ, Burn P. The OB protein (leptin) pathway –a link between adipose tissue mass and central neural networks. Horm Metab Res 1996;28:619–632.
  • Cioffi JA, Shafer AW, Zupancic TJ, Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction. Nat Med 1996;2:585–589.
  • Grunfeld C, Zhao C, Fuller J, Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 1996;97:2152–2157.
  • Ning W, Dantzer R, Freund GG, In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. J Immunol 1998;160: 1393–1401.
  • Shigenaga J, Moser A, Feingold KR, IL-1 beta mediates leptin induction during inflammation. Biochem Biophys Res Commun 1998;244:75–78.
  • Kohl B, Zumbach MS, Borcea V, Tumor necrosis factor increases serum leptin levels in humans. Diabetes Care 1997;20:1880–1886.
  • Halaas JL, Friedman JM, Chait BT, Weight-reducing effects of the plasma protein encoded by the obese gene. [see comments.]. Science 1995;269(5223):543–546.
  • Sobhani I, Bado A, Vissuzaine C, Leptin secretion and leptin receptor in the human stomach. Gut 2000;47:178–183.
  • Baratta M, Saleri R, Mainardi GL, Leptin regulates GH gene expression and secretion and nitric oxide production in pig pituitary cells. Endocrinology 2002;143:551–557.
  • Dong Z, Xu X, Du L, Leptin-mediated regulation of MT1-MMP localization is KIF1B dependent and enhances gastric cancer cell invasion. Carcinogenesis 2013;34(5):974–983.
  • Deboer MD, Li Y. Puberty is delayed in male mice with dextran sodium sulfate colitis out of proportion to changes in food intake, body weight, and serum levels of leptin. Pediatr Res 2011;69: 34–39.
  • Barbier M, Cherbut C, Aube AC, Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 1998;43:783–790.
  • Weigle DS, Duell PB, Connor WE, Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab 1997;82:561–565.
  • Considine RV, Sinha MK, Heiman ML, Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292–295.
  • Gaetke LM, Oz HS, de Villiers WJ, The leptin defense against wasting is abolished in the IL-2-deficient mouse model of inflammatory bowel disease. J Nutr 2002;132:893–896.
  • Tuzun A, Uygun A, Yesilova Z, Leptin levels in the acute stage of ulcerative colitis. J Gastroenterol Hepatol 2004;19:429–432.
  • Karmiris K, Koutroubakis IE, Xidakis C, Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:100–105.
  • Karmiris K, Koutroubakis IE, Kouroumalis EA. Leptin, adiponectin, resistin, and ghrelin–implications for inflammatory bowel disease. Mol Nutr Food Res 2008;52:855–866.
  • Biesiada G, Czepiel J, Ptak-Belowska A, Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea. J Physiol Pharmacol 2012;63:471–481.
  • Caro JF, Sinha MK, Kolaczynski JW, Leptin: the tale of an obesity gene. Diabetes 1996;45:1455–1462.
  • Maffei M, Halaas J, Ravussin E, Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155–1161.
  • Fitzgerald BP, McManus CJ. Photoperiodic versus metabolic signals as determinants of seasonal anestrus in the mare. Biol Reprod 2000;63:335–340.
  • Hotamisligil GS, Arner P, Caro JF, Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409–2415.
  • Breese EJ, Michie CA, Nicholls SW, Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994;106:1455–1466.
  • Reimund JM, Wittersheim C, Dumont S, Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996;39:684–689.
  • Powrie F, Leach MW, Mauze S, Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1994;1:553–562.
  • Kirchgessner TG, Uysal KT, Wiesbrock SM, Tumor necrosis factor-alpha contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997;100:2777–2782.
  • Barbier M, Vidal H, Desreumaux P, Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003;27:987–991.
  • Sitaraman S, Liu X, Charrier L, Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB J 2004;18:696–698.
  • Aurangzeb B, Leach ST, Lemberg DA, Day AS. Assessment of nutritional status and serum leptin in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2011;52:536–541.
  • Franchimont D, Roland S, Gustot T, Impact of infliximab on serum leptin levels in patients with Crohn's disease. J Clin Endocrinol Metab 2005;90:3510–3516.
  • Ballinger A, Kelly P, Hallyburton E, Plasma leptin in chronic inflammatory bowel disease and HIV: implications for the pathogenesis of anorexia and weight loss. Clin Sci (Lond) 1998;94:479–483.
  • Lord GM, Matarese G, Howard JK, Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998;394:897–901.
  • Palmer G, Aurrand-Lions M, Contassot E, Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice. J Immunol 2006;177:2899–2907.
  • Mackey-Lawrence NM, Petri WA, Jr. Leptin and mucosal immunity. Mucosal Immunol 2012;5: 472–479.
  • Howard JK, Lord GM, Matarese G, Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999;104:1051–1059.
  • Siegmund B, Lehr HA, Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002;122:2011–2025.
  • Busso N, So A, Chobaz-Peclat V, Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol. 2002;168:875–882.
  • Bennett BD, Solar GP, Yuan JQ, A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 1996;6:1170–1180.
  • Lord GM, Matarese G, Howard JK, Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leuko Biol 2002;72:330–338.
  • Mattioli B, Straface E, Quaranta MG, Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 2005;174:6820–6828.
  • Napoleone E, DI Santo A, Amore C, Leptin induces tissue factor expression in human peripheral blood mononuclear cells: a possible link between obesity and cardiovascular risk? J Thromb Haemost 2007;5:1462–1468.
  • Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endo Regulat 2009;43:157–168.
  • Zarkesh-Esfahani H, Pockley AG, Wu Z, Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol 2004;172:1809–1814.
  • Martin-Romero C, Santos-Alvarez J, Goberna R, Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000;199:15–24.
  • Fernandez-Riejos P, Goberna R, Sanchez-Margalet V. Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase. Clin Exp Immunol 2008;151:505–518.
  • Fujita Y, Murakami M, Ogawa Y, Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 2002;128:21–26.
  • Farooqi IS, Matarese G, Lord GM, Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093–1103.
  • De Rosa V, Procaccini C, Cali G, A key role of leptin in the control of regulatory T cell proliferation. Immunity 2007;26:241–255.
  • Hasenkrug KJ. The leptin connection: regulatory T cells and autoimmunity. Immunity 2007;26:143–145.
  • Matarese G, Carrieri PB, La Cava A, Leptin increase in multiple sclerosis associates with reduced number of CD4 (+)CD25+ regulatory T cells. Proc Natl Acad Sci USA 2005;102:5150–5155.
  • Coombes JL, Robinson NJ, Maloy KJ, Regulatory T cells and intestinal homeostasis. Immunol Rev 2005;204:184–194.
  • Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295–302.
  • Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003;170:3939–3943.
  • Matarese G, Di Giacomo A, Sanna V, Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol 2001;166:5909–5916.
  • Klingenberg R, Lebens M, Hermansson A, Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Arterioscler Thromb Vasc Biol 2010;30:946–952.
  • Peelman F, Waelput W, Iserentant H, Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. Prog Lip Res 2004;43:283–301.
  • Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Rec Prog Horm Res 2004;59:305–331.
  • Gertler A. Development of leptin antagonists and their potential use in experimental biology and medicine. Tren Endocrinol Metab 2006;17:372–378.
  • Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects.[see comment][erratum appears in J Clin Endocrinol Metab 2000 Jan;85(1):416]. J Clin Endocrinol Metab 1999;84:3686–3695.
  • Mykoniatis A, Anton PM, Wlk M, Leptin mediates Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 2003;124:683–691.
  • Otvos L, Jr., Shao WH, Vanniasinghe AS, Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Peptides 2011;32: 1567–1574.
  • Matarese G, Sanna V, Di Giacomo A, Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Euro J Immunol 2001;31:1324–1332.
  • Garcia-Gonzalea A, Gonzalez-lopez L, Valera-Gonzalez IC, Serum leptin levels in women with systemic lupus erythematosus. Rhaumatol Int 2002;22:138–141.
  • Rey LK, Wieczorek S, Akkad DA, Polymorphisms in genes encoding leptin, ghrelin and their receptors in German multiple sclerosis patients. Mol Cell Probes 2011;25:255–259.
  • Matarese G, Sanna V, Lechler RI, Leptin accelerates autoimmune diabetes in female NOD mice. Diabetes 2002;51:1356–1361.
  • Babaei A, Zarkesh-Esfahani SH, Bahrami E, Ross RJ. Restricted leptin antagonism as a therapeutic approach to treatment of autoimmune diseases. Hormones (Athens) 2011;10:16–26.
  • Ducsay CA, Furuta K, Vargas VE, Leptin receptor antagonist treatment ameliorates the effects of long-term maternal hypoxia on adrenal expression of key steroidogenic genes in the ovine fetus. Am J Physiol Regul Integr Comp Physiol 2013;304:R435–R442.
  • Gionchetti P, Rizzello F, Venturi A, Probiotics in infective diarrhoea and inflammatory bowel diseases ultrasonographic findings in Crohn's disease. [letter; comment.]. J Gastroenterol Hepatolo 2000;15:489–493.
  • Singh UP, Singh S, Taub DD, Lillard JW, Jr. Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10 (-/-) mice. J Immunol 2003;171:1401–1406.
  • Salomon G, Niv-Spector L, Gussakovsky EE, Gertler A. Large-scale preparation of biologically active mouse and rat leptins and their L39A/D40A/F41A muteins which act as potent antagonists. Prote Exp Purifica 2006;47:128–136.
  • Rajapurohitam V, Javadov S, Purdham DM, An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol 2006;41:265–274.
  • Zhang J, Matheny KM, Tümer N, et al. Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent. Am J Physiol Regul Integr Comp Physiol 2007;292(2):R868–R874.
  • Ducroc R, Guilmeau S, Akasbi K, Luminal leptin induces rapid inhibition of active intestinal absorption of glucose mediated by sodium-glucose cotransporter 1. Diabetes 2005;54:348–354.
  • Feuermann Y, Mabjeesh SJ, Niv-Spector L, Prolactin affects leptin action in the bovine mammary gland via the mammary fat pad. J Endocrinol 2006;191:407–413.
  • Singh UP, Singh N, Singh B, Pegylated leptin antagonist ameliorates colitis by inducing regulatory T cells (Tregs) partially mediated by TGF-beta induction. J Immunol 2011;186:162.4–4 (Abstract).
  • Singh UP, Singh NP, Guan H, Leptin antagonist ameliorates chronic colitis in IL-10 −/ − mice. Immunobiology 2013; S0171-2985 (13) 00095-8. doi: 10.1016/j.imbio.2013.04.020. [Epub ahead of print].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.